High-throughput in vitro assays
with dry AMD pathophysiology key features
Learn more with our webinar
on Phenocell's human iPSC-derived Retinal Pigment Epithelium AMD model
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our high-content screening assays can test a large number of compounds in 96wp format.
Identify the most promising compounds before further downstream studies.
- In vitro model that recapitulates key features of dry AMD pathophysiology, with a screenable endpoint (Live/dead cells in 96wp).
- Full phenotypic, molecular and functional characteristics of in situ RPE
Register to our webinar
Blue light exposure
Use our iPSC-derived in vitro model assay
to improve the relevance of
your ophthalmology dry AMD R&D